Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment.

MLA

Ferreira-Silva, Margarida, et al. “Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment.” Pharmaceutics, vol. 14, no. 1, Jan. 2022, p. 104. EBSCOhost, https://doi.org/10.3390/pharmaceutics14010104.

APA

Ferreira-Silva, M., Faria-Silva, C., Carvalheiro, M. C., Simões, S., Marinho, H. S., Marcelino, P., Campos, M. C., Metselaar, J. M., Fernandes, E., Baptista, P. V., Fernandes, A. R., & Corvo, M. L. (2022). Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment. Pharmaceutics, 14(1), 104. https://doi.org/10.3390/pharmaceutics14010104

Chicago

Ferreira-Silva, Margarida, Catarina Faria-Silva, Manuela C. Carvalheiro, Sandra Simões, H. Susana Marinho, Paulo Marcelino, Maria Celeste Campos, et al. 2022. “Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment.” Pharmaceutics 14 (1): 104. doi:10.3390/pharmaceutics14010104.